ARCHIVES

NCI Supercomputer Upgrading Supported By DCBD Board; Could Cost $40 Million Plus Renovations

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Challoner: We Recommended FDA Replace 510(k) Clearance

July 4, 2014

Monoclonal Antibody Improves AML Response To Therapy

July 26, 2002

Oxaliplatin Regimens Extend Survival Of Advanced Colorectal Cancer, Study Finds

June 27, 2003

Survival For ALL Increased To 94 Percent In Recent Years

December 31, 2010

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

April 29, 2011